For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. It may involve scientific site-targeting within the body, or it might involve facilitating systemic pharmacokinetics; in any case, it is typically concerned with both quantity and duration of drug presence. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices or drug-device combination products. Drug delivery is a concept heavily integrated with dosage form and route of administration, the latter sometimes even being considered part of the definition.
The Injectable Drug Delivery market revenue was 353573.88 Million USD in 2022, and will reach 512489.61 Million USD in 2028, with a CAGR of 6.38% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Injectable Drug Delivery industry, and breaks down according to the type, application, and consumption area of Injectable Drug Delivery. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Injectable Drug Delivery in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Injectable Drug Delivery market covered in Chapter 11:
Ypsomed AG
West Pharmaceutical Services, Inc.
Elcam Medical
Insulet Corporation
BD
Eli Lilly and Company
SHL Group
Pfizer Inc.
Gerresheimer AG
In Chapter 3, on the basis of types, the Injectable Drug Delivery market from 2018 to 2028 is primarily split into:
Conventional Injectable
Pre-filled Syringes
Auto-injectors
Pen-injectors
Wearables
In Chapter 4, on the basis of applications, the Injectable Drug Delivery market from 2018 to 2028 covers:
Autoimmune Disorders
Diabetes
Pain Management
Aesthetic Treatments
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2028) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028